Mazabraud Yann (CIK 1774702) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-03). Recent activity: Buy RYTM (12,875 shares), Buy RYTM (10,000 shares), Buy RYTM (5,500 shares), Sell RYTM (6,745 shares), Buy RYTM (10,375 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 12,875 | $0 |
| 2026-02-18 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 10,000 | $0 |
| 2026-02-03 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 5,500 | $0 |
| 2025-05-01 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Sell | 6,745 | $438,965 |
| 2025-04-16 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 10,375 | $0 |
| 2025-04-16 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 11,405 | $0 |
| 2025-04-10 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Sell | 8,438 | $509,402 |
| 2025-04-10 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Sell | 9,312 | $573,060 |
| 2025-03-18 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 75,000 | $1.7M |
| 2025-03-18 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Sell | 19,197 | $975,016 |
| 2025-03-18 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Sell | 55,803 | $2.9M |
| 2025-02-19 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | EVP, Head of International | Buy | 5,500 | $0 |
Source: SEC Form 4 filings · as of 2026-04-03